Acthar
Commercial- Indications
- Multiple sclerosis, Dermatomyositis, Polymyositis, Chronic inflammatory demyelinating polyneuropathy
Company intelligence / Profile preview
Phoenix Neurological Associates provides comprehensive neurological care and has been recognized as a center of excellence for multiple sclerosis, ALS, neuropathies including CIDP and Guillain-Barré syndrome. The group has participated in clinical trials such as Phase II studies of intravenous immunoglobulin therapy for autoimmune-associated small fiber neuropathies. They have also been involved with investigational use of L-serine in neurodegenerative conditions like ALS and Alzheimer’s disease. Their providers are all board-certified neurologists offering both outpatient and inpatient services across the greater Phoenix area.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Phoenix Neurological Associates.